What Genoplan does

Genoplan is a biotechnology company founded in 2014 that specializes in DNA testing and conducts genetic analysis, with operations headquartered in Fukuoka, Japan. The company operates at a small scale (11-50 employees) in the consumer genetic testing space, offering personalized genetic insights — most likely positioned within the broader personalized nutrition and wellness category, which independent market sizing places at a projected $35.1 billion by 2030 with a 15.6% CAGR.

The company's core offering involves collecting consumer DNA samples and returning genetic analysis, although the input does not specify the precise technology stack, lab partnerships, or product variants (e.g., ancestry, health-risk, nutrition, or pharmacogenomic panels). No patents, regulatory certifications, or proprietary AI/ML pipelines are disclosed in the available data, leaving the underlying technical differentiation unclear. The company is led by founder and CEO Byungkyu Brian Kang.

Genoplan has raised approximately $27.8 million across six funding rounds between 2015 and 2020, with investor participation from Samsung Ventures, SBVA, SparkLabs Accelerator, WONIK Investment Partners, CyberAgent, Green Cross (lead on the $13M 2018 round), DAYLI Financial Group, and PIA Investment Management. The mix of Korean strategic corporates (Green Cross, Samsung) and Japanese/Asian venture investors suggests a cross-border go-to-market spanning Korea and Japan. No pricing, customer segmentation, distribution channel, or revenue mechanics are disclosed in the available input.

Name

Genoplan

Legal name

Genoplan

Website

https://genoplan.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Genoplan is a Japanese biotechnology company founded in 2014 that provides direct-to-consumer DNA testing and genetic analysis, primarily serving personalized nutrition and wellness consumers in the Japan/Korea region.

Ownership category

akta.pro rank

Product category

Consumer Genetic Testing

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• DNA testing services
• Genetic analysis
• Consumer genomics
• Personalized genetic testing
• Biotechnology testing

Headquarters

HQ city

Fukuoka

HQ country

Japan

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

Genoplan is a biotechnology company that specializes in DNA testing and conducts genetic analysis, providing consumer-oriented genetic testing and personalized genomic insights. The company operates an online platform through which customers can purchase DNA testing kits and access genetic analysis results.

Differentiator

Problem solved

Functional benefit

Products and services

• DNA testing and genetic analysis service Direct-to-consumer genetic testing service that analyzes DNA samples and delivers personalized genetic insights to individual customers via the Genoplan website.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• 23andMe: Direct-to-consumer DNA testing company offering ancestry, health, and trait reports; competes head-to-head with Genoplan in consumer genetic analysis and personalized insights.
• Ancestry: One of the largest global DTC genetic testing services focused on ancestry and family history; operates in the same consumer genomics category as Genoplan.
• MyHeritage: DTC genetic testing and family-tree platform with growing health and nutrition reports; comparable scope and consumer-facing DNA testing model to Genoplan.
• DNAfit: Genetic testing service specifically oriented toward fitness and nutrition personalization; the closest functional analogue to Genoplan's personalized-nutrition positioning.
• Viome: Personalized nutrition and wellness company combining microbiome and genetic analysis; directly comparable in translating genomic data into tailored nutrition recommendations.

Emerging players

• Prenetics: Asia-Pacific genetic testing and consumer health company; regionally focused peer with overlapping consumer genomics and preventive health offerings.
• easyDNA: Genetic testing provider offering a broad menu of ancestry, health, and relationship tests; comparable as a niche DTC genetic-testing operator.
• Orig3n: Direct-to-consumer genetic testing company focused on wellness, fitness, and nutrition traits; overlaps with Genoplan's personalized-nutrition angle at a similar stage.
• Helix: Consumer genomics platform powering DNA-based products across health, ancestry, and nutrition; comparable sequencing-as-a-service and partner-driven model.

Broad incumbents

• DNA Diagnostics Center: Established genetic testing laboratory offering paternity, ancestry, and health-related tests; broader incumbent in the same genetic-testing services space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/genoplan

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genoplan